Key statistics
As of last trade Biohaven Ltd (BHVN:NYQ) traded at 45.90, -26.22% below its 52-week high of 62.21, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 44.98 |
---|---|
High | 47.15 |
Low | 44.98 |
Bid | 45.88 |
Offer | 45.99 |
Previous close | 45.19 |
Average volume | 866.12k |
---|---|
Shares outstanding | 98.40m |
Free float | 82.69m |
P/E (TTM) | -- |
Market cap | 4.45bn USD |
EPS (TTM) | -9.35 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:25 GMT.
More ▼
- Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
- Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
- Biohaven Announces Proposed Public Offering of Common Shares
- Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
- Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
- Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia
More ▼